Telbivudine
Back to searchMolecule Structure
Scientific Name
Telbivudine
Description of the Drug
Telbivudine is a thymidine nucleoside analog used for the treatment of chronic hepatitis B with clinical evidence of viral replication or persistent elevations in serum aminotransferases (ALT or AST).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01265
http://www.drugbank.ca/drugs/DB01265
Brand Name(s)
Sebivo, Tyzeka
Company Owner(s)
Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA polymerase/reverse transcriptase | SINGLE PROTEIN | INHIBITOR | CHEMBL2362994 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL124279 | |
| PharmGKB | PA164760861 | |
| Human Metabolome Database | HMDB0015394 | |
| DrugBank | DB01265 | |
| PubChem: Thomson Pharma | 15220960 | 15220961 |
| PubChem | 159269 | |
| Mcule | MCULE-7222676614 | |
| LINCS | LSM-45942 | |
| Nikkaji | J515.502I | |
| PDBe | LLT | |
| BindingDB | 50088372 | |
| EPA CompTox Dashboard | DTXSID30187813 | |
| DrugCentral | 4220 | |
| Brenda | 14484 | |
| ChemicalBook | CB42130132 | CB4321891 |
| rxnorm | TELBIVUDINE | |
| PubChem: Drugs of the Future | 12015420 | |
| ChEBI | 63624 | |
| ZINC | ZINC000000002159 |
